Multiple Choice
A pharmaceutical researcher develops a novel antibacterial drug that works by inhibiting exonuclease activity during DNA replication. When actively dividing Escherichia coli is exposed to the drug, enzyme-mediated nucleotide removal in the 5' to 3' direction is impaired, leading to inhibition of bacterial growth. Which of the following enzymes is the most likely target of this drug?
A) DNA polymerase I
B) DNA polymerase III
C) Gyrase
D) Helicase
E) Ligase
F) Primase
Correct Answer:

Verified
Correct Answer:
Verified
Q79: A 25-year-old man experiences severe intolerance to
Q80: In an experiment, cultured fibroblasts are mechanically
Q81: A 28-year-old man is evaluated for abnormal
Q82: A 20-year-old man suddenly collapses while walking
Q83: A 12-year-old girl is brought to the
Q85: A healthy, nulliparous 29-year-old woman with regular
Q86: A 50-year-old previously healthy man is evaluated
Q87: A 5-year-old boy is being evaluated for
Q88: A 33-year-old woman, gravida 2 para 1,
Q89: A small-for-gestational-age infant is born prematurely to